A practical reference on reversed-phase: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-24 and is reviewed periodically as new material appears.
System suitability testing is performed before and during analytical runs to confirm that the instrument and method are working as expected. Typical checks include retention time, peak area precision, resolution between critical pairs, tailing factor, and theoretical plate count. Acceptance criteria are set in the method or pharmacopeial monograph. If a suitability check fails, the run may be rejected and the instrument or sample preparation may need investigation. This practice helps prevent release of data from a system that has drifted out of control.
Quality control samples are inserted at intervals to monitor accuracy and precision throughout a batch. Blank samples detect contamination, while spiked samples assess recovery from the sample matrix. Calibration standards establish the relationship between detector response and concentration, and control samples are prepared independently from them whenever possible. Laboratories also participate in proficiency testing and maintain audit trails, instrument logs, and reagent records. Ongoing review of control charts can reveal trends before they cause out-of-specification results.
Method validation demonstrates that an HPLC procedure is suitable for its intended purpose. Common validation parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantification, and robustness. Accuracy reflects agreement with a reference value, while precision describes repeatability under defined conditions. Specificity shows whether the method can measure the analyte in the presence of impurities or matrix components. Validation documents are reviewed before a method is used for routine testing or regulatory submissions.
Key performance measures include retention time, peak area, peak height, resolution, tailing factor, and plate count. Retention time helps identify a peak under fixed conditions, but confirmation often requires a second method or detector. Peak area and height relate to concentration through calibration curves, which may be linear or nonlinear depending on the detector response. Resolution describes separation between adjacent peaks, while tailing factor and plate count describe peak shape and column efficiency. Performance checks verify these values before and during a run to confirm that the instrument is performing within limits.
High-performance liquid chromatography testing separates components of a liquid sample by forcing a mobile phase through a packed column. The stationary phase inside the column interacts with analytes to different degrees, so each compound exits at a characteristic retention time. A pump delivers solvent at controlled flow and pressure, while an injector introduces a precise sample volume. Detectors such as ultraviolet-visible, fluorescence, refractive index, or mass spectrometric instruments record the separated bands. The resulting chromatogram provides qualitative and quantitative information about the mixture.
| Property | Value | Notes |
|---|---|---|
| Validation parameter | Accuracy | Closeness to a reference value. |
| Validation parameter | Precision | Repeatability or intermediate precision. |
| Validation parameter | Linearity | Proportional response across a range. |
| System suitability check | Resolution | Separation between adjacent peaks. |
| Quality control tool | Control chart | Tracks results over time for trends. |
Reversed-phase chromatography dominates modern HPLC testing, using a nonpolar stationary phase such as chemically bonded octadecyl groups and a polar mobile phase of water mixed with organic solvent. Analytes partition between the mobile and stationary phases according to hydrophobicity. Gradient elution changes the mobile phase composition over time to separate compounds with a wide range of retention. Isocratic elution keeps the composition constant and is simpler for routine assays. Column temperature, pH, and flow rate influence selectivity, peak shape, and retention time, so these parameters are controlled during a validated method.
Detection in HPLC testing commonly relies on ultraviolet-visible absorbance, fluorescence, refractive index, or mass spectrometry. A diode array detector records full spectra across a wavelength range, which helps identify co-eluting peaks. Mass spectrometry provides mass-to-charge ratios and can confirm molecular identity at low concentrations. The choice of detector depends on analyte structure, required sensitivity, and whether quantitation or identification is the goal. No single detector works for every compound, and method development often compares responses before selecting one.
In quality control laboratories, HPLC testing supports batch release, raw material checks, stability studies, and impurity profiling. A validated method defines sample preparation, instrument settings, calibration, and acceptance criteria. Analysts compare results with specifications and investigate out-of-specification outcomes before a batch is approved. Documentation includes chromatograms, integration records, audit trails, and reagent details. Because results influence product decisions, laboratories follow formal quality systems and data integrity rules. The exact tests and limits depend on the material, its intended use, and the applicable regulatory framework.
Method validation examines whether an HPLC procedure is suitable for its intended purpose. Common parameters include accuracy, precision, specificity, linearity, range, detection limit, quantification limit, and robustness. Accuracy describes closeness to a true or accepted value, while precision describes agreement among repeated measurements. Specificity shows whether the method can measure the analyte without interference from related substances. Robustness tests small deliberate changes in flow, temperature, or solvent composition. Validation is not a one-time event; methods may need partial revalidation after changes to instruments, columns, sample handling, or specification limits. Regulatory guidance provides frameworks, but some details remain method-specific.
HPLC testing is an analytical technique used to separate, identify, and quantify components in a liquid sample. It relies on a pressurized mobile phase that carries the sample through a column packed with stationary phase. Different compounds travel at different rates because of interactions with the stationary and mobile phases. The resulting signal versus time is a chromatogram. Peak position indicates identity under specified conditions, while peak area or height relates to amount.
Laboratories apply HPLC testing across pharmaceutical, food, environmental, and industrial chemistry. The method can measure active ingredients, impurities, additives, preservatives, and degradation products. Sample preparation often includes dilution, filtration, and sometimes extraction or derivatization. The choice of column, mobile phase, pH, temperature, and detector depends on the analytes and matrix. Results are compared with reference standards to assign identity and concentration. Method suitability is judged by resolution, precision, and accuracy.
HPLC testing is not a single fixed procedure; it is a family of separation modes. Reversed-phase, normal-phase, ion-exchange, size-exclusion, and affinity chromatography each suit different analyte properties. Reversed-phase methods dominate because they handle many neutral and moderately polar compounds. Detection can be optical, electrochemical, or mass spectrometric, and the detector dictates what information is available. Coupling with mass spectrometry increases selectivity and enables identification when standards are unavailable. The technique cannot separate every mixture without adjustment.
Laidlaw stated that reasons behind the cancellation included the fact that headcrabs and zombies "were pretty much played out at the time", and that the fact that it had to take place chronologically prior to Half-Life 2: Episode Two was too creatively constraining. Footage of the project was shown in a 2020 documentary by media company Noclip titled The Untold History of Arkane.
== Contraindications == Allergy to sulfonylureas or sulfonamides Diabetes mellitus type 1 Diabetic ketoacidosis Patients that underwent removal of the pancreas Acute porphyria Severe liver disease accompanying with liver insufficiency Several conditions (e.g., infectious diseases or major surgical intervention), when insulin administration is required Pregnancy or breastfeeding
On the other side, between 2014 and 2019, the Houthi leadership have signed multiple co-existence agreements with the Salafi community; pursuing Shia-Salafi reconciliation. The Yemeni government has often accused the Houthis of collaborating with al-Qaeda to undermine its control of southern Yemen.
In April 2021 Noakes pleaded guilty in France to manufacturing and selling fake medicinal products and cosmetics by Internet and sentenced to 4 years of jail. A 2019 Business Insider report detailed the activities of Amanda Mary Jewell, who sold GcMAF for years as an unlicensed cure for several medical conditions, including cancer and autism. Jewell is not a medical doctor.
== History == BioDuro was founded in 1996 in the United States as a drug discovery services company. In 2009, it was acquired by Pharmaceutical Product Development (PPD), a leading global contract research organization. In 2020, Advent International merged BioDuro with the China-based CRO Sundia to form BioDuro-Sundia, creating a combined CRDMO serving biotech and pharma clients globally. In 2021, the company expanded its U.S. operations in Irvine to support clinical and commercial drug product manufacturing. In 2025, BioDuro announced new investments in China, including a Bengbu process development and scale-up site and an OEB-5 high-potency laboratory for ADC payloads and HPAPIs.
Sources: en.wikipedia.org
==== Cultivation in the UK ==== In late 2006, the British government permitted the pharmaceutical company MacFarlan Smith (a Johnson Matthey company) to cultivate opium poppies in England for medicinal reasons, after Macfarlan Smith's primary source, India, decided to increase the price of export opium latex. This move is well received by British farmers, with a major opium poppy field located in Didcot, England. The British government has contradicted the Home Office's suggestion that opium cultivation can be legalized in Afghanistan for exports to the United Kingdom, helping lower poverty and internal fighting while helping the NHS to meet the high demand for morphine and heroin. Opium poppy cultivation in the United Kingdom does not need a licence, but a licence is required for those wishing to extract opium for medicinal products.
Former SNP chief executive Peter Murrell appears before Edinburgh Sheriff Court charged with embezzlement, while his estranged wife, former Nicola Sturgeon, is told she will face no further action in the police investigation into SNP finances. Kemi Badenoch launches the Conservative local election campaign at an event in Buckinghamshire. Jo Coburn announces her departure from the BBC and as host of the programme BBC Politics Live. The 2025 City of London Corporation election is held in the City of London. 21 March – SNP MSP Fergus Ewing announces he will not stand for the party at the 2026 Holyrood election, but may run as an independent. Leaked messages deepen the row between Nigel Farage and Rupert Lowe. Rachel Reeves pledges no "tax and spend" in her spring statement. 22 March – The UK government is reported to be considering establishing "return hubs" for failed asylum seekers in the Balkans. 23 March – Chancellor Rachel Reeves confirms plans to reduce government running costs by 15% by the end of the decade. Steve Witkoff, the US special envoy to the Middle East, dismisses Starmer's plan for an international peacekeeping force to support a ceasefire in Ukraine as "a posture and a pose". 25 March – The UK government confirms it is ending a contract with Stay Belvedere Hotels to provide places for asylum seekers after an audit identified concerns about the firm's performance. A report by Jacqueline Perry KC finds "credible evidence" Rupert Lowe and his staff mistreated two female team members in ways that "seem to amount to harassment".
The SAF is being developed to respond to a wide range of issues in both conventional and unconventional warfare. The Defence Science and Technology Agency (DSTA) is responsible for procuring resources for the military. The geographic restrictions of Singapore mean that the SAF must plan to fully repulse an attack, as they cannot fall back and re-group. The small size of the population has also affected the way the SAF has been designed, with a small active force and a large number of reserves.
Rich reported severe side effects from the injections, including emotional blunting and loss of physical sensation. Following a final recommitment order in December 2018, he died by suicide on January 11, 2019, at age 29. His mother, attorney Elizabeth Rich, founded the nonprofit Andrew's V.O.I.C.E. (Victory Over Involuntary Commitment Excesses) to advocate for mental health law reform. His case was documented in a July 2019 investigative article by Robert Whitaker in Mad in America as part of a broader critique of AOT law evidence and practice. A 2023 expert analysis by physician and researcher Peter C. Gøtzsche published in Mad in America documented the case of a Swedish patient, Tuva Andersson, who was forcibly administered paliperidone palmitate depot injections at a forensic psychiatric facility without a confirmed psychotic diagnosis, over her explicit objection. Documented adverse effects included severe muscle stiffness, loss of motor function, and marked cognitive deterioration, which treating clinicians attributed to her underlying condition rather than the medication. An additional medication for Parkinsonism was added rather than the paliperidone being reduced. Andersson died by suicide in 2019, at age 37. A post-mortem assessment by an independent psychiatrist retained by the regional insurance authority concluded that her care had been deficient, that increasing suicide risk had not been met with corresponding interventions, and that her death was likely caused by failures in her treatment.
Sources: en.wikipedia.org
== Contraindications == Lurasidone is contraindicated in individuals who are taking strong inhibitors of the liver enzyme CYP3A4 (ketoconazole, clarithromycin, ritonavir, levodropropizine, etc.) or inducers (carbamazepine, St. John's wort, phenytoin, rifampicin etc.). The use of lurasidone in pregnant women has not been studied and is not recommended; in animal studies, no risks have been found. Excretion in breast milk is also unknown; lurasidone is not recommended for breastfeeding women. The enzyme CYP3A4 is involved in the digestion of drugs. Inhibitors such as grapefruit juice block its function, resulting in too much drug in the body.
is used to control the proportion of amino acids that are unchanged. By using only alignments of proteins that had at least 85% similarity, it could be reasonably assumed that the mutations observed were direct, without any intermediate states. This means that scaling down these counts by a common factor would provide an accurate estimate of the mutation counts had the similarity been closer to 100%. It also means that the number of mutations per 100 amino acids, the
=== Familia Infini === The Japan only special model Familia Infini was introduced in February 1990 to celebrate Mazda's 70th anniversary. Based on the GT saloon, the 1.6 L DOHC B6-ZE engine was swapped to a bigger 1.8 L DOHC BP-ZE engine from the Protegé LX and international market 323 GT (it later became the standard engine for Familia GT in 1991), and teamed with a close ratio LSD 5-speed manual transmission. The Infini was upgraded with a viscous limited-slip differential, stiffer suspension package, and bonnet/headlight from the 323 hatchbacks (in 1991, these were adopted on all Familia saloon models). The Infini came only in dark green color with unique Infini aerodynamic grille, rear spoiler with third stop lamp, "lightweight" carpet, without sound deadener, and with Infini (∞) logos on horn button, front grille, wheel caps, and bootlid. There were also unique factory front clear indicators, a Momo Cobra II steering wheel, BBS 15-inch rims, faux suede interior with GT-X style seat trim, leather gearknob and shift boot, front and rear strut braces, 22-mm sway bars front and rear, rear tie bar, a quick-ratio steering and a 7,250 rpm redline tachometer, as well as 250 mm (9.8 in) four-wheel disc brakes. Around 1,000 Infinis were produced, and preceded Mazda's ɛ̃fini Japanese dealership network.
Sources: en.wikipedia.org
Method validation is the documented process of showing that an HPLC procedure produces reliable results for a defined purpose. It examines parameters such as accuracy, precision, specificity, linearity, and robustness. Regulators and quality systems often require validation before routine use.
System suitability is a set of checks run on the chromatographic system before sample analysis. It confirms that resolution, peak shape, retention time, and response meet predefined limits. Failure can invalidate the run and trigger corrective action.
Blank injections reveal peaks or baseline disturbances that come from solvents, reagents, or the instrument rather than the sample. They help distinguish contamination from actual analyte signals. Comparing blanks with sample runs supports accurate interpretation.
It measures the amounts and identities of compounds in liquid samples by separation and detection. Depending on the detector and reference standards, results can be qualitative or quantitative. The technique is used in fields such as pharmaceutical analysis, food safety, and environmental monitoring.